| 2022-03-03 | Blueprint Medicines Corporation BPMC | 5,000 0.0086% | $59.98 | $299,900 | -8.24% | |||
| 2020-12-24 | Sale | Blueprint Medicines Corporation BPMC | director | 5,455 0.0099% | $125.00 | $681,875 | -21.25% | |
| 2020-12-18 | Sale | Blueprint Medicines Corporation BPMC | director | 5,454 0.0094% | $120.00 | $654,480 | -21.66% | |
| 2020-12-11 | Sale | Blueprint Medicines Corporation BPMC | director | 5,455 0.0098% | $115.00 | $627,325 | -15.55% | |
| 2020-12-01 | Sale | Blueprint Medicines Corporation BPMC | director | 5,454 0.0101% | $110.00 | $599,940 | -8.13% | |
| 2020-10-19 | Sale | Blueprint Medicines Corporation BPMC | director | 5,455 0.0098% | $105.00 | $572,775 | -6.62% | |
| 2020-10-07 | Sale | Blueprint Medicines Corporation BPMC | director | 5,454 0.0098% | $100.00 | $545,400 | -2.33% | |
| 2016-03-04 | GlycoMimetics, Inc. GLYC | director | 20,794 0.1005% | $4.77 | $99,260 | +23.55% |